Characterization of the Interaction Between SARS-CoV-2 Membrane Protein (M) and Proliferating Cell Nuclear Antigen

Érika Pereira Zambalde1, Isadora Carolina Betim Pavan2, Mariana Camargo Silva Mancini1

  • 1Multidisciplinary Laboratory of Food and Health, School of Applied Sciences, University of Campinas (Unicamp), Limeira, Brazil.

Insights

The SARS-CoV-2 M protein interacts with human PCNA, a DNA repair protein. This interaction causes PCNA to move to the cytoplasm, potentially offering a new target for COVID-19 therapies.

Area of Science:

  • Virology
  • Molecular Biology
  • Cell Biology

Background:

  • SARS-CoV-2, the virus causing COVID-19, belongs to the Coronaviridae family.
  • The viral structural membrane (M) protein plays a role in virion structure.
  • Proliferating Cell Nuclear Antigen (PCNA) is crucial for DNA replication and repair and is a marker of DNA damage.

Purpose of the Study:

  • To investigate the interaction between the SARS-CoV-2 M protein and human PCNA.
  • To understand the functional consequences of this interaction in infected cells.
  • To explore potential therapeutic strategies targeting this interaction.

Main Methods:

  • Immunoprecipitation and Proximity Ligation Assay (PLA) to confirm M-PCNA interaction.
  • Immunofluorescence and cell fractionation to track PCNA localization.
  • Immunohistochemistry on patient lung tissue.
  • In vitro plaque formation assays with PCNA translocation inhibitors.

Main Results:

  • Validated the interaction between SARS-CoV-2 M protein and human PCNA.
  • Observed PCNA reallocation from the nucleus to the cytoplasm in infected cells and M protein-transfected cells.
  • Documented increased expression of PCNA and γH2AX (DNA damage marker) in infected cells and COVID-19 patient lungs.
  • Inhibition of PCNA translocation reduced viral plaque formation in vitro.

Conclusions:

  • The SARS-CoV-2 M protein interacts with PCNA, inducing its cytoplasmic translocation.
  • This M-PCNA association may be a viral strategy to manipulate host cell functions.
  • Targeting PCNA translocation presents a potential therapeutic avenue for COVID-19.